Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › ARTV
SUPERSTRING CAPITAL MANAGEMENT LP position in ARTV
LATIGO BIOTHERAPEUTICS INC · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 88,178 shares of ARTV (LATIGO BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.74% of its reported portfolio and ranking #26 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's ARTV position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in ARTV in Q3 2026 at 88,178 shares (US$1.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 88.18K | $1.47M | New |
About ARTV and 13F data
ARTV (LATIGO BIOTHERAPEUTICS INC) is a Health Care company. 82 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), Deep Track Capital, LP (US$73.6M), Blue Owl Capital Holdings LP (US$63.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 17.96M sh · $174.17M · Q2 2026
- Deep Track Capital, LP 4.41M sh · $73.62M · Q3 2026
- Blue Owl Capital Holdings LP 4.13M sh · $63.84M · Q3 2026
- 5AM Venture Management, LLC 2.35M sh · $22.83M · Q2 2026
- Venrock Adviser, LLC 2.04M sh · $19.82M · Q2 2026
- Caligan Partners LP 1.74M sh · $16.84M · Q2 2026
- Sanofi 672.78K sh · $11.24M · Q3 2026
- Samsara BioCapital, LLC 954.86K sh · $9.26M · Q2 2026
- Saturn V Capital Management LP 300.36K sh · $5.02M · Q3 2026
- Propel Bio Management, LLC 696.44K sh · $4.96M · Q3 2026
- Revelation Capital Management, LLC 299.31K sh · $2.13M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K sh · $1.85M · Q3 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held ARTV?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ARTV holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in ARTV?
As of Q3 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 88.18K shares of ARTV (LATIGO BIOTHERAPEUTICS INC), valued at $1.47M, representing 0.74% of its reported portfolio and ranking #26.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling ARTV?
In the latest 13F filing (Q3 2026), SUPERSTRING CAPITAL MANAGEMENT LP newly opened its position in ARTV.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., Deep Track Capital, LP, Blue Owl Capital Holdings LP, among 82 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.